Cryotherapy for chronic rhinitis (IPG771)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 14 September 2023
SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (terminated appraisal) (TA834)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 12 October 2022
Palforzia for treating peanut allergy in children and young people (TA769)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 2 February 2022
Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis (TA708)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 June 2021
Anaphylaxis: assessment and referral after emergency treatment (CG134)Product type:GuidanceProgramme:Clinical guidelineLast updated: 24 August 2020Published: 14 December 2011
Intranasal phototherapy for allergic rhinitis (IPG616)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 13 June 2018
ImmunoCAP ISAC 112 for multiplex allergen testing (DG24)Product type:GuidanceProgramme:Diagnostics guidancePublished: 18 May 2016
Omalizumab for previously treated chronic spontaneous urticaria (TA339)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 8 June 2015
Drug allergy: diagnosis and management (CG183)Product type:GuidanceProgramme:Clinical guidelinePublished: 3 September 2014
Omalizumab for treating severe persistent allergic asthma (TA278)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 April 2013
Pharmalgen for the treatment of bee and wasp venom allergy (TA246)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 February 2012
Food allergy in under 19s: assessment and diagnosis (CG116)Product type:GuidanceProgramme:Clinical guidelinePublished: 23 February 2011
Thora-3Di for assessing asthma in children (MIB122)Product type:AdviceProgramme:Medtech innovation briefingPublished: 2 October 2017
The Airsonett temperature-controlled laminar airflow device for persistent allergic asthma (MIB8)Product type:AdviceProgramme:Medtech innovation briefingPublished: 11 August 2014
Chronic urticaria: off-label doses of cetirizine (ESUOM31)Product type:AdviceProgramme:Evidence summaryPublished: 8 July 2014